Introduction: The Overlooked "Switch" The success of monoclonal antibodies is undeniable, yet the inherent glycosylation heterogeneity remains a hidden variable for efficacy and safety. Fine-tuning the Fc glycan structure directly governs critical immune effector functions like Antibody-Dependent Cellular Cytotoxicity (ADCC) and serum half-life. Traditional production processes...